130 likes | 413 Views
Essential Medicines Programmes Sudan now. Now : Essential Medicines programmes. In 2010 , health expenditures The public per capita expenditure is US$ 40, . Now: NDP. The NDP is increasingly act as a framework for managing the pharmaceutical sector. . Now: Essential Medicines.
E N D
Essential Medicines Programmes Sudan now
Now: EssentialMedicinesprogrammes In 2010 , health expenditures • The public per capita expenditure is US$ 40,
Now: NDP • The NDP is increasingly act as a framework for managing the pharmaceutical sector.
Now: Essential Medicines • It guides the procurement of medicines in the public sector, health insurance, donations, and local medicine production. • It is part of training programme of graduated pharmacists. • Today, both public tender prices and C&F prices for private sector are publically available in websites.
Now: Public SupplySystem • Management system improved significantly • Computerized system at central • SOPs and adherence to basic standards in drug supply management • Monitoring and evaluation systems, • Managerial auditing system • Delivery to states through RDF project • Branch in each state with 8% less in price;
Now: Health Insurance • Coverage is only 30% of population; • Based on essential medicines; • Patient pay 25% of the treatment cost; • Branch in each state
Now: Health Partners • Obtaining health partners and donors support to expand the drug supply & management component; • GF delivering free medicines for the TB, HIV and Malaria • programmes for control neglected and communicable diseases e.g Meningitis outbreaks, • EPI, • RH • EHA, in areas where the Government is not available
Now: Availability • In 2007, the availability essential medicines in public sector was 86% and 95% in private sector • In 2010, availability of essential medicines at public sector was 80.6%, and in private sector was 93.0% In 2007, only 67 % are affordable.
Now: RUM • In 2007; 73% of prescribed medicines in public sector were from the EML, • 45% were prescribed by generic name
Now: Regulations essential medicines • In 2007, independent MRA was established and Policies separated from regulations; • With support of WHO/EC roadmap for QC PQ is in place since 2008. • Pharmaco-vigilance unit established in 2009; • Being Uppsala member supported by EC
Other changes • WHO Good Governance started in 2010 • Pharmaceutical Country Profile, in 2010 • Global Fund Project for 5-years support • Licensed pharmacists was 1.53/10,000 compared to 0.5/10,000 in 1990, • HR mapping was conducted • framework for HRD developed;
Challenges • Fragmented health system, with inequitable distribution of resources; • Verticality of supplies by different programme • Instability of policies towards public supply system; • Poor data and information management system; • Efficacy and quality, yet is a question; • Distribution and delivery at state level; • Accessibility is still low; • Low coverage of health insurance; • Irrational use of medicines (36% of health expenditures); • Capacities to adsorb all available budgets is limited; • Policies implementation and monitoring